SAAD, F.; WINQUIST, E.; HUBAY, S.; BERRY, S.; ASSI, H.; LEVESQUE, E.; AUCOIN, N.; CZAYKOWSKI, P.; LATTOUF, J.-B.; ALLOUL, K.; STEWART, J.; SRIDHAR, S. S. Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Canadian Urological Association Journal, [S. l.], v. 10, n. 3-4, p. 102–9, 2016. DOI: 10.5489/cuaj.3470. Disponível em: https://cuaj.ca/index.php/journal/article/view/3470. Acesso em: 4 may. 2024.